ViroGates Statistics

Total Valuation

ViroGates has a market cap or net worth of DKK 93.59 million. The enterprise value is 91.46 million.

Market Cap	93.59M
Enterprise Value	91.46M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

ViroGates has 7.73 million shares outstanding. The number of shares has increased by 92.36% in one year.

Current Share Class	n/a
Shares Outstanding	7.73M
Shares Change (YoY)	+92.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	43.89%
Owned by Institutions (%)	n/a
Float	3.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.76
PB Ratio	11.00
P/TBV Ratio	13.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.91
EV / Sales	12.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.61

Financial Position

The company has a current ratio of 8.30, with a Debt / Equity ratio of 0.75.

Current Ratio	8.30
Quick Ratio	6.05
Debt / Equity	0.75
Debt / EBITDA	n/a
Debt / FCF	-0.44
Interest Coverage	-19.12

Financial Efficiency

Return on equity (ROE) is -183.84% and return on invested capital (ROIC) is -65.69%.

Return on Equity (ROE)	-183.84%
Return on Assets (ROA)	-57.39%
Return on Capital (ROIC)	-65.69%
Revenue Per Employee	724,800
Profits Per Employee	-1.32M
Employee Count	10
Asset Turnover	0.51
Inventory Turnover	0.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.00% in the last 52 weeks. The beta is 0.94, so ViroGates's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+29.00%
50-Day Moving Average	11.65
200-Day Moving Average	7.77
Relative Strength Index (RSI)	45.17
Average Volume (20 Days)	9,539

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViroGates had revenue of DKK 7.25 million and -13.23 million in losses. Loss per share was -2.05.

Revenue	7.25M
Gross Profit	5.45M
Operating Income	-13.14M
Pretax Income	-13.80M
Net Income	-13.23M
EBITDA	-13.10M
EBIT	-13.14M
Loss Per Share	-2.05

Full Income Statement

Balance Sheet

The company has 7.43 million in cash and 5.30 million in debt, giving a net cash position of 2.13 million or 0.28 per share.

Cash & Cash Equivalents	7.43M
Total Debt	5.30M
Net Cash	2.13M
Net Cash Per Share	0.28
Equity (Book Value)	7.09M
Book Value Per Share	1.10
Working Capital	12.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.02 million and capital expenditures -1,000, giving a free cash flow of -12.02 million.

Operating Cash Flow	-12.02M
Capital Expenditures	-1,000
Free Cash Flow	-12.02M
FCF Per Share	-1.55

Full Cash Flow Statement

Margins

Gross margin is 75.22%, with operating and profit margins of -181.24% and -182.57%.

Gross Margin	75.22%
Operating Margin	-181.24%
Pretax Margin	-190.38%
Profit Margin	-182.57%
EBITDA Margin	-180.75%
EBIT Margin	-181.24%
FCF Margin	n/a

Dividends & Yields

ViroGates does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.36%
Shareholder Yield	-92.36%
Earnings Yield	-16.97%
FCF Yield	-12.84%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ViroGates has an Altman Z-Score of 2.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.35
Piotroski F-Score	n/a